Review of the national usage of antibiotics in arthroplasty surgery: a need for evidence-based prescribing
The Annals of The Royal College of Surgeons of England · 2024
DOI: 10.1308/rcsann.2022.0145 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Annals of The Royal College of Surgeons of England, 2024. Verfasst von H Hassanzadeh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Homerton University Hospital NHS Foundation Trust, UK. Hauptthemen laut MEDLINE: Antibiotic Prophylaxis, Surgical Wound Infection, Anti-Bacterial Agents, Arthroplasty. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Surgical site infections (SSI) remain one of the most serious complications of arthroplasty surgery. The role of antibiotic prophylaxis in preventing SSI post-arthroplasty is well established. However, there is considerable heterogeneity in prophylactic prescribing across the United Kingdom (UK), which is contradicted by the contemporaneous evidence. This descriptive study aimed to compare the current first-line antibiotic recommendations across hospitals in the UK and The Republic of Ireland for elective arthroplasty procedures.
Methods
The MicroGuide mobile phone application was used to access hospital antibiotic guidelines. First-line antibiotic recommendation and dosing regimen for primary elective arthroplasties were recorded.
Findings
A total of nine distinct antibiotic regimens were identified through our search. The most frequently used first-line antibiotic was cefuroxime. This was recommended by 30 of the 83 (36.1%) hospitals in the study. This was followed by a combination of flucloxacillin and gentamicin, which was used by 38 of 124 (31%) hospitals. There was also significant heterogeneity in dosing regimens. A single prophylactic dose was most commonly recommended (52%); 4% of hospitals recommended two prophylactic doses, 19% three doses and 23% four doses.
Conclusions
Single-dose prophylaxis is recognised as at least noninferior to multiple-dose prophylaxis in primary arthroplasty. There is considerable variation in the local antibiotic recommendations for surgical site prophylaxis post-primary arthroplasty surgery, with respect to both recommended first-line antibiotic and dosing regimens. With increasing emphasis on the importance of antibiotic stewardship and the emergence of antibiotic resistance, this study highlights the need for an evidence-based approach to prophylactic dosing across the UK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Homerton University Hospital NHS Foundation Trust, UK.
Zitieren
APA
Hassanzadeh, H., Ferro, A., Woods, K., & Baring, T. (2024). Review of the national usage of antibiotics in arthroplasty surgery: a need for evidence-based prescribing. The Annals of The Royal College of Surgeons of England. https://doi.org/10.1308/rcsann.2022.0145
Vancouver
Hassanzadeh H, Ferro A, Woods K, Baring T. Review of the national usage of antibiotics in arthroplasty surgery: a need for evidence-based prescribing. The Annals of The Royal College of Surgeons of England. 2024. doi:10.1308/rcsann.2022.0145
BibTeX
@article{Hassanzadeh2024,
author = {Hassanzadeh, H and Ferro, A and Woods, K and Baring, T},
title = {Review of the national usage of antibiotics in arthroplasty surgery: a need for evidence-based prescribing},
journal = {The Annals of The Royal College of Surgeons of England},
year = {2024},
doi = {10.1308/rcsann.2022.0145}
}
EUVIMED